FI64365C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat Download PDFInfo
- Publication number
- FI64365C FI64365C FI782847A FI782847A FI64365C FI 64365 C FI64365 C FI 64365C FI 782847 A FI782847 A FI 782847A FI 782847 A FI782847 A FI 782847A FI 64365 C FI64365 C FI 64365C
- Authority
- FI
- Finland
- Prior art keywords
- therapeutic
- methyl
- pyridyl
- compounds
- naphth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU78140 | 1977-09-19 | ||
| LU78140 | 1977-09-19 | ||
| CH814978 | 1978-07-28 | ||
| CH814978 | 1978-07-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI782847A FI782847A (fi) | 1979-03-20 |
| FI64365B FI64365B (fi) | 1983-07-29 |
| FI64365C true FI64365C (fi) | 1983-11-10 |
Family
ID=25702876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI782847A FI64365C (fi) | 1977-09-19 | 1978-09-18 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US4182766A (cs) |
| EP (1) | EP0001279B1 (cs) |
| JP (1) | JPS5459274A (cs) |
| AR (1) | AR224350A1 (cs) |
| AT (1) | AT368152B (cs) |
| AU (1) | AU519711B2 (cs) |
| BG (1) | BG28708A3 (cs) |
| BR (1) | BR7806148A (cs) |
| CA (1) | CA1106849A (cs) |
| DD (1) | DD138210A5 (cs) |
| DE (2) | DE2840591A1 (cs) |
| DK (1) | DK406578A (cs) |
| EG (1) | EG13530A (cs) |
| ES (1) | ES473451A1 (cs) |
| FI (1) | FI64365C (cs) |
| FR (1) | FR2403340A1 (cs) |
| GB (1) | GB2004281B (cs) |
| GR (1) | GR73069B (cs) |
| HU (1) | HU176111B (cs) |
| IE (1) | IE47363B1 (cs) |
| IL (1) | IL55557A (cs) |
| IN (1) | IN148930B (cs) |
| IT (1) | IT1098858B (cs) |
| MC (1) | MC1213A1 (cs) |
| MT (1) | MTP835B (cs) |
| NL (1) | NL7809529A (cs) |
| NO (1) | NO149962C (cs) |
| NZ (1) | NZ188405A (cs) |
| OA (1) | OA06054A (cs) |
| PH (1) | PH16342A (cs) |
| PL (1) | PL114494B1 (cs) |
| PT (1) | PT68573A (cs) |
| RO (1) | RO75258A (cs) |
| SE (1) | SE7809792L (cs) |
| SU (1) | SU793390A3 (cs) |
| YU (1) | YU216778A (cs) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4321372A (en) * | 1980-06-16 | 1982-03-23 | Pfizer Inc. | Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| US4368201A (en) * | 1981-07-20 | 1983-01-11 | Usv Pharmaceutical Corporation | Tetrahydronaphthoxazoles |
| IL66340A (en) * | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
| HU191757B (en) * | 1983-05-03 | 1987-04-28 | Byk Gulden Lomberg Chem Fab | Process for producing new tricyclic ethers |
| ZW4585A1 (en) * | 1984-04-19 | 1985-11-20 | Hoffmann La Roche | Imidazole derivatives |
| EP0174717B1 (en) * | 1984-07-06 | 1992-01-22 | FISONS plc | Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors |
| GB2161160B (en) * | 1984-07-06 | 1989-05-24 | Fisons Plc | Heterocyclic sulphinyl compounds |
| SE8404065D0 (sv) * | 1984-08-10 | 1984-08-10 | Haessle Ab | Novel biologically active compounds |
| DE3501497A1 (de) * | 1985-01-18 | 1986-07-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| US5869513A (en) * | 1985-05-24 | 1999-02-09 | G. D. Searle & Co. | 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines |
| EP0204215B1 (en) | 1985-05-24 | 1993-08-11 | G.D. Searle & Co. | 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines |
| DK337086A (da) * | 1985-08-12 | 1987-02-13 | Hoffmann La Roche | Benzimidazolderivater |
| SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
| SE8600658D0 (sv) * | 1986-02-14 | 1986-02-14 | Haessle Ab | Novel composition of matter |
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
| SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
| NZ222495A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
| SE8604998D0 (sv) | 1986-11-21 | 1986-11-21 | Haessle Ab | Novel pharmacological compounds |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| DE3701277A1 (de) * | 1987-01-17 | 1988-07-28 | Boehringer Mannheim Gmbh | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel |
| US4931557A (en) * | 1988-10-17 | 1990-06-05 | Eli Lilly And Company | Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof |
| EG19302A (en) * | 1988-12-22 | 1994-11-30 | Haessle Ab | Compound with gastric acid inhibitory effect and process for its preparation |
| SE8804628D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New compounds |
| SE8804629D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
| US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
| US5274099A (en) * | 1989-12-20 | 1993-12-28 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
| US5049674A (en) | 1989-12-20 | 1991-09-17 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
| SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
| HUT71885A (en) * | 1992-07-08 | 1996-02-28 | Monsanto Co | Process for preparing a composition containing benzimidazoles for treatment stomach ulcer in swine |
| AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
| PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| KR100463031B1 (ko) * | 1997-05-26 | 2005-04-06 | 동아제약주식회사 | 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법 |
| US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
| US20040248942A1 (en) * | 2003-02-20 | 2004-12-09 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| WO2005007115A2 (en) * | 2003-07-18 | 2005-01-27 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
| US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| EP2068841B1 (en) | 2006-10-05 | 2018-09-26 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| WO2008057802A2 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
| WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985661A (en) * | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
| GB1234058A (cs) * | 1968-10-21 | 1971-06-03 | ||
| SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
-
1978
- 1978-08-30 IN IN949/CAL/78A patent/IN148930B/en unknown
- 1978-08-31 MC MC781323A patent/MC1213A1/xx unknown
- 1978-09-11 US US05/941,343 patent/US4182766A/en not_active Expired - Lifetime
- 1978-09-12 IL IL55557A patent/IL55557A/xx unknown
- 1978-09-13 BG BG040865A patent/BG28708A3/xx unknown
- 1978-09-13 AU AU39817/78A patent/AU519711B2/en not_active Expired
- 1978-09-13 CA CA311,181A patent/CA1106849A/en not_active Expired
- 1978-09-13 NZ NZ188405A patent/NZ188405A/xx unknown
- 1978-09-13 EG EG554/78A patent/EG13530A/xx active
- 1978-09-14 FR FR7826420A patent/FR2403340A1/fr active Granted
- 1978-09-14 YU YU02167/78A patent/YU216778A/xx unknown
- 1978-09-14 OA OA56607A patent/OA06054A/xx unknown
- 1978-09-14 DK DK406578A patent/DK406578A/da not_active Application Discontinuation
- 1978-09-14 PH PH21603A patent/PH16342A/en unknown
- 1978-09-15 DD DD78207858A patent/DD138210A5/xx unknown
- 1978-09-18 PT PT68573A patent/PT68573A/pt unknown
- 1978-09-18 DE DE19782840591 patent/DE2840591A1/de not_active Withdrawn
- 1978-09-18 SE SE7809792A patent/SE7809792L/xx unknown
- 1978-09-18 GB GB7837156A patent/GB2004281B/en not_active Expired
- 1978-09-18 FI FI782847A patent/FI64365C/fi not_active IP Right Cessation
- 1978-09-18 AT AT0673378A patent/AT368152B/de not_active IP Right Cessation
- 1978-09-18 SU SU782664651A patent/SU793390A3/ru active
- 1978-09-18 EP EP78100923A patent/EP0001279B1/de not_active Expired
- 1978-09-18 ES ES473451A patent/ES473451A1/es not_active Expired
- 1978-09-18 MT MT835A patent/MTP835B/xx unknown
- 1978-09-18 NO NO783155A patent/NO149962C/no unknown
- 1978-09-18 DE DE7878100923T patent/DE2861237D1/de not_active Expired
- 1978-09-18 IE IE1878/78A patent/IE47363B1/en unknown
- 1978-09-18 GR GR57249A patent/GR73069B/el unknown
- 1978-09-18 HU HU78HO2102A patent/HU176111B/hu unknown
- 1978-09-18 JP JP11371578A patent/JPS5459274A/ja active Pending
- 1978-09-19 AR AR273765A patent/AR224350A1/es active
- 1978-09-19 RO RO7895228A patent/RO75258A/ro unknown
- 1978-09-19 NL NL7809529A patent/NL7809529A/xx not_active Application Discontinuation
- 1978-09-19 BR BR7806148A patent/BR7806148A/pt unknown
- 1978-09-19 PL PL1978209693A patent/PL114494B1/pl unknown
- 1978-09-19 IT IT27861/78A patent/IT1098858B/it active
-
1979
- 1979-07-02 US US06/054,210 patent/US4248880A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI64365C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 1hnaft(2,3-d)-imidazolderivat | |
| FI87565B (fi) | Analogifoerfarande foer framstaellning av antibakteriellt aktiva 6-fluor-7-diazabicykloalkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat | |
| DE69300255T2 (de) | 8-Chlor-11-(1-(5-methyl-3-pyridyl)methyl-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)-pyridin. | |
| CS203970B2 (en) | Method of producing novel heterocyclyl-oxy-hydroxy-amino-propanes | |
| US4560693A (en) | [1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles | |
| CZ20011082A3 (cs) | Tetrahydropyridoethery | |
| JPH0524917B2 (cs) | ||
| US4083983A (en) | Alkoxy pyridine compounds | |
| DE3782621T2 (de) | Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen. | |
| PL181801B1 (pl) | Podstawione aryloalkilotioalkilotiopirydyny do zwalczania bakterii Helicobacter oraz srodek leczniczy zawierajacy podstawione aryloalkilotioalkilotiopirydyny PL | |
| PL151696B1 (en) | Method of obtaining derivatives of quinolone | |
| KR100549631B1 (ko) | 시아노구아니딘, 이의 제조방법 및 이를 함유하는 약제학적 제제 | |
| EP1838696B1 (en) | Novel cyanoguanidine compounds | |
| DE3782636T2 (de) | Isoindolin-1-on-derivat und antiarrhythmisches mittel. | |
| US4154838A (en) | Alkoxy pyridine | |
| CN110256405B (zh) | 5-烃基-n-取代芳基吡啶酮衍生物及其制备方法和用途 | |
| KR900004694B1 (ko) | 신규 α-아릴-α-피리딜 알카노인산 유도체의 제조방법 | |
| EP0251294B1 (en) | Substituted isoquinoline derivatives and anti-ulcer agents | |
| DE60013607T2 (de) | Bemzimidazolverbindungen und medikamente die diese enthalten | |
| US4076717A (en) | Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid | |
| US4389403A (en) | 1-Aroyl-2-phenylamino-2-imidazolines, drugs containing these compounds, and use thereof | |
| US5114954A (en) | Antiinflammatory benzylselenobenzamides from aminopyridines and picolylamines | |
| DE60007748T2 (de) | Benzimidazolderivate und sie enthaltende medikamente | |
| DE69014426T2 (de) | Thioformamide Derivate. | |
| DE10238045A1 (de) | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: F. HOFFMANN-LA ROCHE & CO. AG |